Updated results from OCTAVIA (front-line bevacizumab, carboplatin and weekly paclitaxel therapy for ovarian cancer)

Antonio Gonzalez-Martin, Laurence Gladieff, Bengt Tholander, Daniel Stroyakovsky, Martin Gore, Giovanni Scambia, Ana Oaknin, Vesna Sneller, Ulrich Freudensprung, Sandro Pignata

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)862-863
Number of pages2
JournalEuropean Journal of Cancer
Volume50
Issue number4
DOIs
Publication statusPublished - Mar 2014

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Gonzalez-Martin, A., Gladieff, L., Tholander, B., Stroyakovsky, D., Gore, M., Scambia, G., Oaknin, A., Sneller, V., Freudensprung, U., & Pignata, S. (2014). Updated results from OCTAVIA (front-line bevacizumab, carboplatin and weekly paclitaxel therapy for ovarian cancer). European Journal of Cancer, 50(4), 862-863. https://doi.org/10.1016/j.ejca.2013.12.001